Bioethics News

Cost for New Oral Cancer Drugs Skyrocketed in Last Decade

April 29, 2016

(UPI) – A new drug for cancer introduced in 2014 costs about six times the price of a new drug in 2000, with the cost of many other drugs to treat the disease increasing in price significantly during that time, according to a new study. Researchers at the University of North Carolina found the skyrocketing prices line up with changes in health insurance making patients responsible for more of the cost and potentially put people in the position of not being able to afford treatment.

The views, opinions and positions expressed by these authors and blogs are theirs and do not necessarily represent that of the Bioethics Research Library and Kennedy Institute of Ethics or Georgetown University.